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Chronic Diarrhea in Dogs – Retrospective Study in 136 Cases
M. Volkmann , J.M. Steiner, G.T. Fosgate, J. Zentek, S. Hartmann, and B. Kohn
Background: Chronic diarrhea (CD) is common in dogs, and information on frequency and distribution of primary and
secondary causes is lacking.
Objectives: To evaluate underlying causes and predictors of outcome in dogs with CD.
Animals: One hundred and thirty-six client-owned dogs with CD (≥3 weeks duration).
Methods: Retrospective review of medical records (Small Animal Clinic, Freie Universit€at Berlin, Germany, 09/2009-07/
2011). Quantiﬁcation of ﬁnal diagnoses and comparison of clinical aspects including disease severity and clinicopathological
abnormalities among dogs with clinical remission (either complete [gastrointestinal signs absent] or partial [clinical improve-
ment of gastrointestinal signs and reduced episodes with shortened duration]), and those without recovery.
Results: Ninety percent of dogs were diagnosed with a primary enteropathy: inﬂammatory (71%; of those 66% dietary
responsive, 23% idiopathic, 11% antibiotic responsive), infectious (13%), neoplastic (4%), and in one dog each mechanical
disease or systemic vasculitis. Secondary causes were diagnosed in 10% of dogs: exocrine pancreatic (6%), endocrine (2%),
and in one dog each hepatic, renal, and cardiac disease. In total, 87% of dogs had clinical remission, whereas 13% died or
did not respond to treatment: Lack of recovery was frequently recorded for dogs with primary inﬂammatory (idiopathic) or
neoplastic disease and was signiﬁcantly associated with increased disease severity scores (P = .005), anemia (hemat-
ocrit < 40%, P < .001), severe hypoalbuminemia (serum albumin <2.0 g/dL, P = .008), and severe hypocobalaminemia
(serum cobalamin concentration <200 pg/mL, P = .006).
Conclusions and clinical importance: Inﬂammatory enteropathies and particularly those of dietary origin were the most
common causes of CD in dogs. Findings support the usefulness of hematocrit, and serum albumin and cobalamin concentra-
tion as prognostic markers in dogs with CD.
Key words: Enteropathy; Epidemiology; Inﬂammatory bowel disease; Outcome.
Chronic intermittent or persistent diarrhea is a com-mon clinical sign in dogs with chronic enteropathy
and might be a manifestation of gastrointestinal or
extragastrointestinal disorders.1 Extragastrointestinal
disorders (i.e, secondary enteropathies) include diseases
of the exocrine pancreas, the liver, and the kidneys as
well as endocrinopathies and diseases of the
cardiovascular or central nervous system. The cause of
gastrointestinal disorders (i.e, primary enteropathies)
can be infectious, neoplastic, mechanical, toxic, or non-
infectious inﬂammatory.1,2 Noninfectious inﬂammatory
causes include dietary and antibiotic responsive entero-
pathies as well as idiopathic inﬂammatory diseases that
require anti-inﬂammatory or immunosuppressive treat-
ment. The diﬀerent causes of respective chronic inﬂam-
matory enteropathies (CIE) appear phenotypically
similar upon histological evaluation of a tissue biopsy
and are diagnosed retrospectively by their response to
sequential treatment trials involving diet(s), antibiotics,
and anti-inﬂammatory/immunosuppressive drugs.3–7
CIE is considered to be the most common cause of
chronic gastrointestinal disease in dogs.1,7,8 However,
information concerning the frequency and distribution
of underlying primary and secondary causes of chronic
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diarrhea in dogs is lacking. Thus, the prevalence of the
various causes of CIE is unknown.a,1,8,9 Clinicopatho-
logical ﬁndings and clinical aspects such as the localiza-
tion to small or large bowel diarrhea might be useful to
clarify underlying causes.2,8
The principal objective of this study was to quantify
the ﬁnal diagnoses in a large number of dogs with
chronic diarrhea and to investigate the hypotheses that
noninfectious inﬂammatory enteropathies (CIE) are the
most frequent causes of chronic diarrhea. Further
objectives were to evaluate clinical and clinicopathologi-
cal abnormalities associated with an adverse clinical
outcome in (1) the overall population of dogs with
chronic diarrhea and (2) in dogs with speciﬁc diagnoses
causing chronic diarrhea.
Materials and Methods
Medical records of dogs with chronic diarrhea that were pre-
sented to the Clinic for Small Animals, Freie Universit€at Berlin,
Germany, between September 2009 and July 2011, were retro-
spectively reviewed. Dogs were included if diarrhea had been pre-
sent for 3 weeks or longer and a minimum work-up had been
performed, which included hematology, plasma biochemistry pro-
ﬁle, and fecal ﬂotation and Giardia ELISA. Other diagnostic
modalities included serum analyses for cobalamin, folate, canine
trypsin-like immunoreactivity, canine-speciﬁc pancreatic lipase
and cortisol/adrenocorticotropic hormone stimulation test, urinal-
yses, abdominal radiographs and ultrasound, as well as fecal
microbiology and rectal scrapings. Endoscopy of the gastrointesti-
nal tract or laparotomy with collection of tissue biopsies and
histopathologic evaluation of intestinal biopsies were recom-
mended in dogs with suspected inﬂammatory and neoplastic dis-
eases. A stepwise approach was performed to further characterize
noninfectious inﬂammatory enteropathies: initially, dogs were fed
an elimination diet of home-cooked novel protein diet or hypoal-
lergenic diet,b commercial exclusion diet,c or a combination
thereof. Food responsive enteropathy (FRE) was deﬁned as the
positive clinical response to an elimination diet, and the diet was
continued for at least 4–8 weeks. If no clinical improvement was
observed within 2–4 weeks, it was recommended to change the
diet or move to the next therapeutic trial with metronidazole
(10 mg/kg BW, PO, q 12 h) or tylosin (25 mg/kg BW, PO, q 12
h) for another empirical treatment period of at least 10 days. A
positive clinical response to antibiotic treatment deﬁned the diag-
nosis of antibiotic responsive enteropathy (ARE). Dogs that nei-
ther responded to diet nor to antibiotics, and that required anti-
inﬂammatory/immunosuppressive treatment such as prednisolone
at 0.5–1.0 mg/kg BW, PO, q 12–24 h, or cyclosporine at 5 mg/kg
BW, PO, q 24 h were diagnosed as having idiopathic inﬂamma-
tory bowel disease or steroid responsive enteropathy (IBD). Dogs
were excluded from the study if a ﬁnal diagnosis was not
recorded.
Information obtained from the medical records: sex, age, body
weight, breed size (criteria were based on breed descriptions from
the Federation Cynologique Internationale: small-sized, which is
any breed with a height at withers <30 cm; medium-sized, which is
any breed with a height at withers 30–50 cm; and large-sized,
which is any breed with a height at withers ≥50 cm),10 body condi-
tion score (BCS, 5-integer scale: 1, thin; 2, underweight; 3, ideal
weight; 4, overweight; 5, obese),d feces consistency, frequency, and
abnormalities including melena, mucus, or blood in feces and
tenesmus, secondary clinical signs such as changes in appetite or
activity level, weight loss, vomiting, abdominal pain, borborygmi,
ﬂatulence, and pruritus, predominant gastrointestinal site of
disease according to presenting clinical signs,1,2 duration of clinical
signs before presentation (3 to 6 weeks, 6 weeks to 6 months, 6 to
12 months, more than 1 year), and clinicopathological abnormali-
ties. The canine IBD activity index (CIBDAI) was used to assess
disease severity and was based on the parameters: weight loss,
appetite, activity level, feces consistency, feces frequency, and vom-
iting.11 Furthermore, follow-up information was obtained from the
medical records or by contacting the owners via telephone or
e-mail up to one year after initial presentation (Fig 1). Response
to treatment was deﬁned as either complete recovery (CR; marked
improvement with the absence of gastrointestinal signs), partial
recovery (PR; clinical improvement with reduction of gastrointe-
stinal signs and reduced episodes with shortened duration), or
no recovery (NR; no response to treatment, dog died or was
euthanized).
Statistical analyses were performed by statistical software pack-
ages (i.e, SPSS, IBM SPSS statistics campus, Ehningen, Germany;
version 20 and GraphPad Prism software, La Jolla, California,
USA; version 5). Characteristics, clinical aspects, and outcome
were compared between dogs with primary or secondary causes,
and among selected groups of dogs with the same ﬁnal diagnoses
with a group size of at least 5 dogs. Final diagnoses with a group
size of 3 followed by 4 dogs were descriptively analyzed. Charac-
teristics, clinical, and clinicopathological abnormalities were com-
pared among diﬀerent groups of dogs based on outcome.
Clinicopathological abnormalities identiﬁed to be associated with
an adverse clinical outcome were compared among dogs with a
diﬀerent predominant site of disease and among groups of dogs
with selected ﬁnal diagnoses. Pearson chi-square or Fisher’s exact
tests were used to compare categorical variables, and results are
given as percentages. Median and range are presented for quanti-
tative variables and Mann-Whitney U-tests or Kruskal-Wallis tests
were used to compare continuous variables between 2 or more
groups, respectively. Mann-Whitney U-tests with Bonferroni cor-
rection of P values were used for posthoc comparisons. Statistical
signiﬁcance was set at P < .05.
Results
Final Diagnoses
Two hundred and nine dogs with chronic intermitt-
ent or persistent diarrhea were presented during the
2 year study period, and 136 cases fulﬁlled the inclusion
criteria.
Primary enteropathies (PE) were diagnosed in 123 of
136 dogs (90%), and chronic inﬂammatory enteropa-
thies were the most frequent causes within this group
(n = 97, 79%) (Fig 2): Sixty-four dogs improved after
feeding an elimination diet (home-cooked novel protein
diet, n = 28; hypoallergenic diet,b n = 25; combined
home-cooked and hypoallergenic diet, n = 5; commer-
cial exclusion diet,c n = 6) and were therefore diagnosed
as FRE. ARE was diagnosed in 11 cases (positive clini-
cal response to metronidazole, n = 9, or tylosin, n = 2),
and 22 dogs were diagnosed with IBD. Histopathologic
analyses of gastrointestinal biopsies were performed in
34 dogs with chronic inﬂammatory enteropathies: a
lymphocytic-plasmacytic inﬂammation was identiﬁed in
8 dogs, an eosinophilic inﬂammation in 2, and a mixed
inﬂammatory cell inﬁltrate in 18 dogs. In 6 cases, no
abnormality was identiﬁed (Table 1).
An infectious cause was identiﬁed in 18 of 136
dogs (13%): A parasitic infection was diagnosed in
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Fig 2. Distribution of primary and secondary causes and frequencies of underlying causes of chronic diarrhea in 136 dogs. Bar graphs
representing frequencies of total. PE, primary enteropathy; SE, secondary enteropathy; FRE, food responsive enteropathy (n = 64); ARE,
antibiotic responsive enteropathy (n = 11); IBD, idiopathic inﬂammatory bowel disease (n = 22).
Fig 1. Questionnaire to deﬁne outcome groups in dogs with chronic diarrhea. *There was no dog that fulﬁlled these criteria.
Table 1. Descriptive results for the histopathologic analyses of gastrointestinal biopsies from 34 dogs with chronic
inﬂammatory enteropathies.
Total (n = 34) FRE (n = 13) ARE (n = 5) IBD (n = 16)
Severity grade NAD 6 3 2 1
Mild 12 4 2 6
Moderate 12 5 1 6
Severe 4 1 – 3
Dominant inﬂammatory cell type NAD 6 3 2 1
Lymphocytic-plasmacytic 8 2 – 6
Eosinophilic 1 – 1 –
Eosinophilic and histiocytic 1 – – 1
Mixed 18 8 2 8
FRE, food responsive enteropathy; ARE, antibiotic responsive enteropathy; IBD, idiopathic inﬂammatory bowel disease; NAD, no
abnormality detected.
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16 dogs, which clinically improved after antiparasitic
therapy (Giardia spp., n = 13; mixed infection with
Giardia spp., Coccidia, and Toxocara spp., n = 2;
Leishmania spp., n = 1). Systemic infection with
Prototheca zopﬁi genotype II was identiﬁed in 2
cases.
Lymphoma was diagnosed in 5 of 136 cases (4%)
and was the most frequent neoplastic disease. A col-
orectal adenocarcinoma was identiﬁed in one dog.
Colonic intussusception led to chronic bloody diar-
rhea in a young German Shepherd dog, and systemic
vasculitis was diagnosed in one German Shepherd
dog.
Secondary enteropathies (SE) were diagnosed in 13 of
136 dogs (10%) (Fig 2): Diseases of the exocrine pan-
creas were the most frequent extragastrointestinal
causes (8 of 136 cases, 6%: exocrine pancreatic insuﬃ-
ciency, n = 4; chronic pancreatitis, n = 3; pancreatic
adenocarcinoma, n = 1). Endocrine disorders occurred
in two dogs (atypical hypoadrenocorticism and
hypothyroidism in one dog each). Hepatic, renal, or
cardiovascular diseases were identiﬁed in 3 dogs, one
with a portosystemic shunt, one with chronic kidney
disease, and one with chronic heart failure.
Dog Characteristics
Male dogs were overrepresented in the study popula-
tion with a male/female ratio of 1.3 in dogs with PE
and 2.3 in dogs with SE (Table 2). Middle-aged dogs
(≥2 to <9 years) were most frequently presented
(n = 69, 51%), followed by old dogs (9 years and older:
n = 37, 27%), and young dogs (less than 2 years:
n = 30, 22%; including 4 dogs younger than 1 year). In
comparison, dogs diagnosed with PE were younger than
dogs with SE. More speciﬁcally, dogs diagnosed with
Giardia spp. infection were the youngest, followed by
dogs with ARE, FRE, and exocrine pancreatic insuﬃ-
ciency (Table 2). Dogs belonged to 47 diﬀerent breeds
with mixed-breed dogs being most frequently presented
(n = 35, 26%). Of those 7 were Terriers, 6 Labrador
Retrievers, and 5 German Shepherd mixed-breeds.
Common pure-bred dogs were German Shepherd dogs
(n = 13, 10%), Yorkshire Terriers (n = 9, 7%), Dachs-
hund (n = 8, 6%), and Boxers (n = 5, 4%). There was
no breed signiﬁcantly overrepresented in PE or SE (data
not shown). Dogs with PE were often large-sized
(n = 60, 49%), whereas dogs with SE were more fre-
quently medium-sized (n = 6, 46%) (Table 2). A thin-
to-underweight body condition score (BCS 1-2) was
common in both groups (PE, n = 74, 60%; SE, n = 9,
69%) (Table 2). Characteristics were not signiﬁcantly
diﬀerent between dogs with PE and SE, and among
selected diagnoses (except age) (Table 2).
Outcome and Clinical Findings
Clinical ﬁndings on the time of ﬁrst presentation and
outcome were known for 127 dogs (PE, n = 116; SE,
n = 11). Two-thirds of dogs were rechecked at the
clinic, whereas for the remainder of the dogs follow-up
information was obtained by contacting the owners via
telephone or e-mail: One hundred and eleven dogs
(87%) achieved clinical remission with 68 dogs being
classiﬁed as complete recovery (CR) and 43 cases as
partial recovery (PR). The remaining 16 dogs (13%) did
not respond to treatment (n = 2), died, or were eutha-
nized due to uncontrolled disease (n = 14), respectively.
Dogs with no recovery (NR) had PE (n = 15) or SE
(n = 1), and the following ﬁnal diagnoses were identi-
ﬁed: IBD (n = 7), intestinal lymphoma (n = 5), pro-
tothecosis (n = 2), systemic vasculitis, and pancreatic
adenocarcinoma (both n = 1). Dogs with NR were sig-
niﬁcantly older than dogs in clinical remission
(P = .018, Table 2).
A moderate disease severity (CIBDAI score 6-8) was
most frequently identiﬁed in the study population
(n = 54, 42%) followed by severe (CIBDAI score ≥9:
n = 44, 35%), mild (CIBDAI score 4-5: n = 24, 19%),
and clinically insigniﬁcant disease (CIBDAI score ≤3:
4%) (Table 2). Severe disease was signiﬁcantly more
common in dogs with IBD and intestinal lymphoma
and was furthermore recorded in all 3 dogs with
chronic pancreatitis (Table 2). Disease severity was not
signiﬁcantly diﬀerent between dogs with PE or SE
(Table 2). Disease severity scores were signiﬁcantly
higher in dogs with NR when compared to dogs in
remission (P = .005; Fig 3A, Table 2).
Disease was localized to the small intestine (SI,
n = 42, 33%) or the large intestine (LI, n = 36, 28%) or
was diﬀuse (DI, n = 49, 39%) (Table 2). Disease sever-
ity scores were signiﬁcantly lower in dogs with predomi-
nantly large bowel diarrhea (CIBDAI score median/
range: SI, 8/3-15; LI, 6/2-14; DI, 8/4-16; P = .002;
Fig 3B). LI was common in PE (Fig 4A) and was most
frequently recorded in dogs with Giardia spp. infection,
ARE, or FRE (Table 2). Clinical signs predominantly
involving the small intestine were signiﬁcantly more
common in dogs with SE (PE: SI, n = 33, 28%; LI,
n = 36, 31%; DI, n = 47, 41%; SE: SI, n = 9, 82%; DI,
n = 2, 18%; P = .001; Fig 4A, Table 2). Moderate-to-
severe vomiting was identiﬁed to be signiﬁcantly more
frequent in dogs with SE (PE, n = 32, 28%; SE, n = 7,
64%; P = .034). However, vomiting in general was
commonly recorded in both dogs with PE and SE (PE,
n = 82, 71%; SE, n = 8, 73%; P = 1.000). No other
evaluated clinical sign was associated with PE or SE
(data not shown). Disease localization was not signiﬁ-
cantly diﬀerent among the 3 groups of dogs based on
outcome (P = .241, Fig 4B, Table 2). However, a few
clinical signs predominantly involving the small intestine
were signiﬁcantly associated with NR: watery diarrhea
(CR n = 36, 53%; PR n = 20, 47%; NR n = 14, 88%;
P = .017), weight loss (CR, n = 25, 37%; PR, n = 17,
40%; NR, n = 14, 88%; P = .001), and lethargy (CR,
n = 1, 2%; PR, n = 1, 2%; NR, n = 3, 20%; P = .019).
Clinical signs had been present for 3 to 6 weeks in 21%
of dogs (n = 26), up to 6 months in 31% (n = 40), up to
1 year in 16% (n = 20), or more than 1 year in 32% of
dogs (n = 41). Duration of disease was not signiﬁcantly
diﬀerent between PE and SE, or among the 3 outcome
groups (P = .514, resp. P = .260; data not separately
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shown). Vomiting and pruritus were associated with
duration of disease: Dogs with moderate-to-severe vomit-
ing were commonly presented earlier than dogs with mild
or without vomiting (moderate-to-severe vomiting,
n = 39: 3 to 6 weeks, n = 14, 36%; up to 6 months,
n = 9, 23%; up to 1 year, n = 8, 20%; more than 1 year,
n = 8, 20%; mild or no vomiting, n = 88: 3 to 6 weeks,
n = 12, 14%; up to 6 months, n = 31, 35%; up to 1 year,
n = 12, 14%; more than 1 year, n = 33, 38%; P = .012).
Pruritus was recorded for 49 of 108 dogs (45%), and pro-
longed disease duration of more than 6 months was com-
mon in these dogs (3 to 6 weeks, n = 7, 14%; up to
6 months, n = 10, 20%; up to 1 year, n = 13, 27%; more
than 1 year, n = 19, 39%; P = .011). Pruritus was fre-
quently recorded in dogs with ARE and IBD, but diﬀer-
ences among selected diagnoses were not statistically
signiﬁcant (FRE, n = 21, 38%; IBD, n = 11, 70%; ARE,
n = 7, 70%; Giardia spp., n = 4, 50%; intestinal lym-
phoma, n = 1, 20%; P = .069). The presence of pruritus
was not signiﬁcantly diﬀerent between outcome groups,
disease severity groups, or between localization groups
(outcome: CR, n = 26, 45%; PR. n = 20, 54%; NR.
n = 3, 23%; P = .157; disease severity: clinically
insigniﬁcant, n = 1, 20%; mild, n = 13, 62%; moderate,
n = 18, 38%; severe, n = 17, 49%; P = .206; localiza-
tion: SI, n = 14, 44%; LI, n = 11, 36%; DI, n = 24, 53%;
P = .296).
Clinicopathological Findings
Hematocrit and serum albumin, calcium, and cobal-
amin concentration were signiﬁcantly lower in dogs
with no remission than in dogs that responded to treat-
ment (Fig 5, Table 3). Thus anemia (hematocrit <40%),
severe hypoalbuminemia (serum albumin concentration
<2.0 g/dL), and severe hypocobalaminemia (serum
cobalamin concentration <200 pg/mL) were signiﬁcantly
associated with a poor clinical outcome (anemia: CR,
n = 5, 7%; PR, n = 3, 7%; NR, n = 9, 56%; P < .001;
severe hypoalbuminemia in CR, n = 1, 2%; PR, n = 5,
12%; NR, n = 5, 31%; P = .008; and severe hypocobal-
aminemia: CR, n = 7, 11%; PR, n = 9, 21%; NR,
n = 6, 55%; P = .003). Hypocalcemia (total calcium
<2.5 mmol/L) was recorded in 26 of 123 dogs (median:
2.23 mmol/L; range: 1.46–2.44 mmol/L). Initial statisti-
cal analyses revealed a signiﬁcant association of
hypocalcemia and poor clinical outcome (CR, n = 9,
14%; PR, n = 10, 23%; NR, n = 7, 44%; P = .031;
Table 3), but after the correction for hypoalbuminemia,
the serum calcium concentration was only subnormal in
Fig 3. Disease severity in dogs with chronic diarrhea according
to outcome (A) and predominant site of disease (B). Box-and-
whiskers plots showing median, range, and 25th to 75th per-
centiles. *P < .05 and **P < .01 for Kruskal-Wallis comparison of
diﬀerences among medians followed by Mann-Whitney U-tests
and Bonferroni adjustment for multiple comparisons. CIBDAI,
canine inﬂammatory bowel disease activity index; CR, complete
recovery; PR, partial recovery; NR, no recovery; SI, small intesti-
nal disease; LI, large intestinal disease; DI, diﬀuse intestinal
disease.
Fig 4. Comparison of predominance of clinical signs between
groups of dogs with either primary or secondary enteropathy (A)
and among outcome in dogs with chronic diarrhea (B). Pearson
chi-square or Fisher’s exact tests were used to compare categorical
variables. Statistical signiﬁcance was set at P < .05. PE, primary
enteropathy; SE, secondary enteropathy; CR, complete recovery;
PR, partial recovery; NR, no recovery; SI, small intestinal disease;
DI, diﬀuse intestinal disease; LI, large intestinal disease.
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one dog with IBD and partial remission (no ionized cal-
cium measurement was available for that dog). No fur-
ther clinicopathological abnormalities were signiﬁcantly
diﬀerent among the 3 outcome groups (Fig 5).
Subset analyses revealed that anemia was common,
and severe hypoalbuminemia and severe hypocobal-
aminemia were signiﬁcantly associated with small
intestinal disease (anemia: SI, n = 10, 24%; LI, n = 3,
8%; DI, n = 4, 8%; P = .053; severe hypoalbumine-
mia: SI, n = 8, 20%; LI, 0%; DI, n = 3, 6%; P = .008;
hypocalcemia: SI, n = 15, 37%; LI, n = 2, 6%; DI,
n = 9, 19%; P = .005; severe hypocobalaminemia: SI,
n = 14, 36%; LI, n = 2, 6%; DI, n = 6, 13%;
P = .004, Table 4) and with certain diagnoses: Hemat-
ocrit was frequently low in dogs with IBD and intesti-
nal lymphoma (P < .001, Table 4), and in dogs with
exocrine pancreatic insuﬃciency (Table 4). Low serum
albumin and calcium concentrations were common in
dogs with IBD (P < .001 and P = .001, Table 4).
Serum cobalamin concentrations were frequently low in
dogs with FRE, IBD, and EPI (Table 4). However, sev-
ere hypocobalaminemia was signiﬁcantly associated
with IBD (FRE, n = 8, 13%; ARE, n = 1, 9%; IBD,
n = 9, 45%; Giardia sp. infection, n = 3, 21%;
P = .016) and was furthermore present in 2 of 4 dogs
with exocrine pancreatic insuﬃciency.
Discussion
Primary enteropathies were identiﬁed with the highest
frequency with noninfectious inﬂammatory enteropa-
thies constituting the most frequent cause of chronic
diarrhea in dogs with an overall frequency of 71%.
Results of the present study are consistent with the
hypothesis that the chronic inﬂammatory enteropathy is
the most common cause of chronic diarrhea, and the
ﬁndings of the present study are substantiated by recent
observations in dogs with various gastrointestinal signs.e,f
Food responsive enteropathy (FRE) was the most fre-
quent ﬁnal diagnosis in the present study with an over-
all frequency of 47% (66% of all dogs with a chronic
inﬂammatory enteropathy). FRE was diagnosed based
on response to an elimination diet, which has been pro-
ven to be the most eﬀective method for diagnosis and
treatment.1,8,12 Diﬀerentiation between food allergy
(immunological reaction) and food intolerance (nonim-
munological reactions) could not be made as both food
allergy and food intolerance manifest themselves with
diarrhea or vomiting or both and are hence clinically
indistinguishable.1,8,12 Thirty-eight percent of dogs diag-
nosed with FRE were presented with pruritus, which
might be suggestive for an allergic reaction to food.1
However, pruritus might also occur in dogs with food
intolerance,1,12 and thus it remains unknown whether
reactions to food were immunological or not. Neverthe-
less, ﬁndings coincide with other studies demonstrating
that approximately 1/2 to 2/3 of dogs with chronic
inﬂammatory enteropathies have FRE, with the remain-
der having antibiotic responsive or idiopathic inﬂamma-
tory bowel disease (IBD) with an approximately equal
Fig 5. Comparison of clinicopathological abnormalities among
outcome groups. Box-and-whiskers plots showing median, range
and 25th to 75th percentiles for hematocrit (A), serum albumin
(B), total serum calcium (C), and cobalamin (D). *P < .05 and
***P < .001 for Kruskal-Wallis comparison of diﬀerences among
medians followed by Mann-Whitney U-tests and Bonferroni
adjustment for multiple comparisons. CR, complete recovery; PR,
partial recovery; NR, no recovery.
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frequency of 15–20%.e,f,5,13 In accordance with other
reports, the ﬁndings of the present study demonstrate
that idiopathic IBD is common in dogs, but that it is not
the most common cause of chronic diarrhea in dogs.a,13
Chronic inﬂammatory enteropathies are multifactorial
disease complexes. An adverse immune response to envi-
ronmental factors including dietary and microbial anti-
gens is likely to be important in the pathogenesis and
might further inﬂuence endoparasites.1,14,15 The ﬁndings
of the present study highlight the need for a detailed and
stepwise diagnostic work-up including therapeutic trials
to eliminate the possibility of parasitic infections and to
exclude diet responsive and antibiotic responsive entero-
pathies before a suspicion of idiopathic IBD can be
substantiated.a,e,f,1,13
In line with other studies, neoplastic causes were less
frequent primary enteropathies and of those, intestinal
lymphoma was the most frequent gastrointestinal neo-
plasia with an overall frequency of 4% in the present
study.e,f,16 Histopathologic evaluation of intestinal biop-
sies remains an important diagnostic tool to diﬀerenti-
ate IBD and intestinal lymphoma, but the latter might
be a result of chronic lymphocytic-plasmacytic inﬂam-
mation, which is the most common type of chronic
intestinal inﬂammation.1,6–8,17–21 Whether dogs diag-
nosed with chronic lymphocytic-plasmacytic or mixed
inﬂammation developed intestinal lymphoma later on
was not evaluated in the present study (i.e, postmortem
examinations and adjunctive techniques such as
immunohistochemistry, ﬂow cytometry, and PCR for
antigen receptor rearrangements were not
performed),19,21,22 and thus underlying intestinal lym-
phoma could have been missed, which is a limiting fac-
tor of the present study.
Parasitic infections were the second leading cause of
chronic diarrhea in the dogs in this study. Giardia has
been recognized as a common parasitic infection caus-
ing gastrointestinal disease and was the predominant
infectious cause in the present study with an overall fre-
quency of 11% of the study population, which is lower
than previously reported in a European multicenter
study (28%).23 However, the frequency of parasitic
causes of chronic enteropathies in canine studies ranges
from less than 2% to more than 30%.1,23,24 The ﬁnd-
ings of the present study were comparable to recent
reports of 9 to 18%.e,f Infectious causes evaluated in
this study were limited to parasitic or algae infections,
and no viral or obligate enteropathogenic bacteria were
identiﬁed as a primary cause of chronic diarrhea. Poten-
tially pathogenic organisms can be frequently found in
the feces of clinically healthy dogs and dogs with
chronic enteropathy making it diﬃcult to determine
whether a speciﬁc organism identiﬁed acts as an etio-
logic factor, is a result of a changing microbiota due to
the chronic enteropathy, or is in fact unrelated to the
disease process.4,24–29 With respect to the multifactorial
etiology of chronic enteropathies, the resolution of clini-
cal signs after elimination of the identiﬁed organism is
essential to determine disease causation.1,30 Thus a par-
asitic infection was diagnosed as the primary cause of
chronic diarrhea based on fecal testing and clinical
response to appropriate antiparasitic therapy (e.g, fen-
bendazole).1 Routine bacteriological and virological
analyses of feces from dogs with diarrhea are not war-
ranted for several reasons, including the usually acute,
mild, and self-limiting character of many bacterial and
viral infections, presentation with characteristic clinical
or laboratory features, relatively brief period of virus
shedding, and diﬃculties with interpretation of culture
results.1,31 Routine analyses are indicated in dogs with
hemorrhagic diarrhea, pyrexia, and an inﬂammatory
leukogram.1,31 In the present study bacteriological cul-
tures were performed in 51 of 136 dogs (36%) without
identifying bacterial infection as a primary cause. Dur-
ing follow-up, Campylobacter spp. was detected in the
feces of one dog with IBD, which had presented with
acute watery diarrhea but ultimately with a self-limiting
course of disease. Although ﬁndings of the present
study are in line with recent observations,e,f,13 several
primary causes might have been missed, as not all dogs
had all testing performed.
In clear contrast to primary enteropathies, extragas-
trointestinal causes (i.e, secondary enteropathies) were
less frequently recorded, with diseases of the exocrine
pancreas being the most common extragastrointestinal
diseases. The overall frequency of secondary enteropa-
thies in the dogs evaluated for the current study was
10%, which is lower than other studies in dogs with
various gastrointestinal signs (17 and 26%).e,f In line
with other studies, frequent vomiting was signiﬁcantly
associated with secondary enteropathies.e,f Thus diﬀer-
ences in the prevalence of primary and secondary
enteropathies are attributed to the inclusion criteria
that only dogs with diarrhea (either with or without
vomiting) had been included into the present study.
Exclusion of dogs without a ﬁnal diagnosis might have
had an impact on the distribution of primary and sec-
ondary enteropathies within the overall population of
dogs with chronic diarrhea and, subsequently, might
have biased the distribution of dietary responsive,
antibiotic responsive, and idiopathic IBD within the
group of dogs with chronic inﬂammatory enteropathies.
During the 2 year study period, 65% of dogs fulﬁlled
the inclusion criteria, and the remainder of dogs was
excluded based on the lack of a ﬁnal diagnosis. Some
dogs were lost to follow-up as they were presented only
once for an initial detailed work-up and were then trea-
ted by their general practitioner. The major problems
for missing ﬁnal diagnoses were poor owner or dog
compliance, which are important factors aﬀecting diag-
nostic and therapeutic success of many forms of
chronic enteropathies.32,33 However, ﬁndings of the pre-
sent study are in line with recent observations suggest-
ing that the impact of excluded cases might only be
marginal.e,f,13
Underlying diseases such as systemic protothecosis
and leishmaniosis as well as mechanical disorders, endo-
crinopathies, and diseases of the liver, kidney, and the
cardiovascular system were uncommon causes of chronic
diarrhea with frequencies less 1% in the present study.
Although these conditions appear to be rare in dogs with
chronic intermittent or persistent diarrhea, they might
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become acutely life-threatening and should therefore not
be ignored during the diagnostic work-up.e,f,1,2
Additionally, we evaluated characteristics, outcome,
and associated clinical and clinicopathological abnormal-
ities in the overall study population, and in particular in
dogs with selected diagnoses (i.e, diagnoses that had been
assigned to at least 3 dogs). Results reported in this study
coincide largely with other reports.f,5,13,17,34-36 To date,
no sex predisposition had been described in dogs with
gastrointestinal disease, although an overrepresentation
of intact males followed by spayed females had been
described in several studies.f,17,18,20,36-39 Intact males were
clearly overrepresented in the present study. However, a
formal comparison to the hospital population over the
same time period was not performed, and therefore, the
clinical importance of the ﬁnding of the present study
remains unknown.
The physical appearance of feces as well as the
appearance of secondary clinical signs such as vomiting,
weight loss, abdominal pain, borborygmi, ﬂatulence,
and alterations in appetite might help to diﬀerentiate
between small and large intestinal disease, which might
be useful to clarify the underlying cause.2,8 In the pre-
sent study, clinical signs of predominantly small bowel
diarrhea were signiﬁcantly more common in dogs with
extragastrointestinal causes when compared to dogs
with primary enteropathies. The presence of moderate-
to-severe vomiting was more common in dogs with sec-
ondary enteropathies, and these results are consistent
with a recent study.e These ﬁndings suggest that extra-
gastrointestinal disease leads to secondary diarrhea, and
vomiting might have been the principal reason for pre-
sentation in these dogs. Interestingly, vomiting was
observed to be signiﬁcantly more common in dogs with
short disease duration, suggesting that owners might
rate vomiting as an alert sign.
Furthermore, small intestinal disease was more com-
mon in dogs with a poor clinical outcome, and clinical
signs such as watery diarrhea, weight loss, and
lethargy appear to be of prognostic value. Overall,
poor clinical outcomes had been observed in 13% of
cases, which is comparable to previous studies.f,5,17,34
Eighty-seven percent of dogs achieved either complete
or partial remission. Craven et al.17 described IBD
cases that achieved remission times of 3 years before
relapse. In the present study, the duration of follow-
up varied and was limited to 1 year; relapses there-
after might have been missed. Due to the retrospective
nature of this study, interpretation of outcome factors
needs to be carried out with caution. The clinical
activity score (CIBDAI) used in the present study has
been shown to be less powerful to accurately predict
long-term disease outcome.5 The assessment of ascites
and pruritus, as well as adding low serum albumin
concentrations to the CIBDAI increases the predictive
ability of clinical disease severity scoring (canine
chronic enteropathy clinical activity index = CCECAI).5
Thus, it is possible that the current study could have
been improved if the CCECAI would have been used
to assess the outcome. However, this was not possible
because the information available in the records of the
present study for pruritus and ascites did not match
the criteria points deﬁned by the CCECAI score. Also,
the current study might have been improved if compar-
isons of ﬁndings before and after treatment could have
been performed. However, follow-up information was
limited in some dogs for a variety of reasons, including
the retrospective study design and the diversity in data
acquisition by diﬀerent clinicians during follow-up.
Therefore, clinical and clinicopathological abnormalities
were only analyzed at the time of ﬁrst presentation,
and criteria for treatment outcome were limited to few
questions, including whether the dog is still alive and
whether gastrointestinal signs improved. Variation in
dietary, antibiotic, and anti-inﬂammatory/immunosup-
pressive treatments reduced further the comparability of
groups. Response to treatment was associated with the
disease classiﬁcation of chronic inﬂammatory enteropa-
thies because a diagnosis of FRE and ARE were based
on a clinical response (either complete or partial) to
dietary or antibiotic treatments, and failure to respond
suggests the presence of IBD, lymphoma, or a rare
condition. IBD and intestinal lymphoma were the most
frequent diagnoses associated with a poor clinical out-
come. A further limiting factor of the present study is
variations in prior treatments that might have inﬂu-
enced the evaluation of clinical and clinicopathological
abnormalities on the time of ﬁrst presentation. Never-
theless, ﬁndings among outcome groups, and in particu-
lar among subsequent analyses of selected diagnoses
(e.g, chronic inﬂammatory enteropathies), are largely in
agreement with other reports.f,5,13,16-18,20,34,36 Subsequent
analyses substantiate original ﬁndings by Allenspach
and others (2007) that younger dogs with less severe
and predominantly large bowel disease are more likely
to be diet responsive and have a good prognosis.5 On
the contrary, older age, high disease severity scores,
and predominantly small intestinal disease were associ-
ated with a poor clinical outcome.f,5,13,16-18,20,34,36
Similar to previous studies, clinicopathological abnor-
malities such as anemia (hematocrit <40%), severe hyp-
oalbuminemia (serum albumin concentration <2.0 g/dL),
and severe hypocobalaminemia (serum cobalamin
concentration <200 pg/mL) were poor prognostic
indicators.f,5,13,17,34,36,40 Subsequent analyses demon-
strated that these clinicopathological abnormalities were
common in dogs with small intestinal disease. Anemia
might indicate chronic inﬂammation or chronic intestinal
blood loss, which is common in dogs with IBD or intesti-
nal lymphoma.18,41 Serum albumin concentrations are
routinely measured in dogs with gastrointestinal disease,
and it has been shown previously that hypoalbuminemia
occurs in dogs with increased disease severity that is asso-
ciated with a poor clinical outcome.5,13,17,34,36 In line with
other reports, severe hypoalbuminemia was common in
dogs with IBD and is most likely attributed to protein-
losing enteropathy, a heterogeneous group of diseases
with nonselective and excessive loss of plasma proteins
into the intestinal lumen.1,5,13,17,36 Serum cobalamin is a
potentially useful marker of intestinal malabsorption and
particularly of small intestinal disease.1,42 A severe
decrease of serum cobalamin concentration was most
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frequently recorded in dogs with IBD and exocr-
ine pancreatic insuﬃciency.13,42,43 The overall frequency
of hypocobalaminemia in dogs with chronic diarrhea
was 44% and an approximate frequency of 30% of dogs
had a low-normal serum cobalamin concentration
(300–400 pg/mL) conﬁrming that concentrations within
the reference interval do not exclude the possibility of
intestinal disease.42 Seventy percent of dogs received
cobalamin supplementation for approximately 16 weeks,
which might have aﬀected the response to treatment and
outcome in these cases.5,44 Measurement of serum cobal-
amin concentration was often but not always repeated
4 weeks after the last cobalamin injection. Furthermore,
follow-up measurements were not available in most cases
with an adverse clinical outcome, thus a comparison of
pre- and post-treatment cobalamin concentration was
not performed.
Conclusion
This study highlights underlying causes and ﬁnal diag-
noses in a large number of dogs with chronic diarrhea.
Chronic inﬂammatory enteropathies and, in particular,
food responsive enteropathies were the most frequent
causes of chronic diarrhea in dogs. Diarrhea is the cardi-
nal sign of intestinal dysfunction but dogs might also be
presented due to secondary clinical signs that might or
might not be accompanied by diarrhea. Moderate-to-
severe vomiting was signiﬁcantly associated with sec-
ondary enteropathies suggesting that extragastrointesti-
nal disease might lead to secondary diarrhea. Clinical
and clinicopathological abnormalities at the time of ﬁrst
presentation were compared among dogs with complete,
partial, or no recovery. Clinical signs predominantly
involving the small intestine and particularly weight loss
and lethargy were signiﬁcantly associated with an
adverse clinical outcome. The ﬁndings of this study are
consistent with previous studies suggesting that anemia,
severe hypoalbuminemia, and severe hypocobalamine-
mia are associated with a poor prognosis and thus high-
light the importance of measuring these parameters in
dogs with chronic signs of gastrointestinal disease. These
clinical and clinicopathological ﬁndings have prognostic,
but not diagnostic value.
Footnotes
a Willard M. Chronic Small Bowel Diarrheas: IBD is Not the
Most Common Cause. In: CVC, Washington, D.C. 2014.
b Hill‘s Prescription Diet z/d
c Hill‘s Prescription Diet Canine d/d, VetConcept Dog Sana
d Rade C. Compliance bei Reduktionsdi€aten - So macht der Besit-
zer mit. kleintierkonkret 2009;4:11-16.
e Baumgart K, Volkmann M, Steiner JM, et al. Final Diagnoses
in 155 Dogs with Chronic Vomiting and/or Diarrhea. In: 24th
ECVIM-CA Congress, Mainz 2014;ESCG-P-10.
f Kuehn M. Retrospektive Analyse chronischer Enteropathien
beim Hund. Doctoral thesis, LMU Munich; 2012.
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